Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.
Oxidative stress has been related to the development of diabetic neuropathy. Experimental diabetes (alloxan injection of mice) promotes early biochemical changes in peripheral nervous tissue, e.g. decrease in Na,K-ATPase activity and glutathione (GSH) peroxidase (GSHPx) activity. The former decrease can be reverted by inhibiting protein kinase C (PKC), since it has been reported that PKC is activated in these experimental conditions. Here we present data demonstrating that the inhibition of PKC, as early as 4 days after alloxan administration, is not able to return to normal values GSHPx activity in sciatic nerve of diabetes mice. Thus, it would fit with our previous proposal of the possible glycation of this protein as an early event in experimental diabetes, and apparently rules out the control of GSHPx activity by PKC in this tissue.
Martínez-Blasco
A
A
Department of Physiology, School of Medicine and Dentistry, University of Valencia, Spain.
Bosch-Morell
F
F
Trenor
C
C
Romero
F J
FJ
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000201:enzymology / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005979:Glutathione Peroxidase / Q000378:metabolism; D008297:Male; D051379:Mice; D009281:Naphthalenes / Q000494:pharmacology; D018384:Oxidative Stress / Q000502:physiology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D012584:Sciatic Nerve / Q000201:enzymology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D009281:Naphthalenes; D005979:Glutathione Peroxidase; D011493:Protein Kinase C; D000254:Sodium-Potassium-Exchanging ATPase; C058819:calphostin C